Graded Differentiation of Glioma in GSK-3 β: The Study and Analysis of the Expression Difference and Its Significance in the Endoplasmic Reticulum Stress Apoptosis Pathway

IF 0.5 4区 医学 Q4 NEUROSCIENCES
Hong Song, Guoliang Mao, Nanlin Jiao, Wanwan Gao, Rui Pang
{"title":"Graded Differentiation of Glioma in GSK-3 β: The Study and Analysis of the Expression Difference and Its Significance in the Endoplasmic Reticulum Stress Apoptosis Pathway","authors":"Hong Song, Guoliang Mao, Nanlin Jiao, Wanwan Gao, Rui Pang","doi":"10.1134/s1819712424020156","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Abstract</h3><p>Glioma accounts for 80% of malignant central nervous system, with high incidence and extremely difficult to cure. However, for the role of ER stress apoptosis in tumor has caused great attention, the neuronal polarity molecule glycogen synthase kinase-3 β(GSK-3 β) endoplasmic network stress apoptosis pathway in tumor mechanism is a hot research in recent years, but for GSK-3 β ER stress apoptosis pathway in different levels of glioma research is extremely rare. In this experiment, we jointly explored the significance of GSK-3 β ER apoptosis pathway in different grades of glioma, which provided a strong basis for the precise treatment of glioma. 35 inpatients from December 2021 to December 2022 were enrolled into the different grades of glioma group and the normal control group. Tumor tissue was classified according to medical pathology. The other five normal brain tissues were obtained from the normal brain tissue of the fistula created in non-functional areas. One of the brain samples was stored for the apoptosis index (AI) of TUNEL (chromogenic method), and another part was stored in liquid nitrogen for the expression of GRP78, IRE 1, ATF 6, PERK, p-Tyr216-GSK-3 β, p-Ser 9-GSK-3 β, and Caspase-3. The AI values of different grades of glioma and normal control groups showed that the normal control, low-grade glioma and high-grade glioma groups were 8. 131 ± 0.234, 68.523 ± 1.392 and 22. 421 ± 0.236, respectively. The AI value was higher in the glioma group than in the normal controls (<i>P</i> &lt; 0.05), while the AI value in the glioma group was negatively correlated with its malignancy (<i>r</i> = –0.725, <i>P</i> = 0.000). Western blot showed: compared with the normal control group, apoptosis initiation protein GRP78 expression, IRE 1, ATF 6, PERK decreased (<i>P</i> &lt; 0.05); pathway key protein p-Ser 9-GSK-3 β increased, and p-Tyr216-GSK-3 β decreased (<i>P</i> &lt; 0.05); pathway executive protein Caspase-3 increased (<i>P</i> &lt; 0.05). However, the apoptosis initiation protein GRP78, IRE 1, ATF 6, PERK increased (<i>P</i> &lt; 0.05); pathway key protein p-Ser 9-GSK-3 β decreased and p-Tyr216-GSK-3 β was increased (<i>P</i> &lt; 0.05); pathway execution protein Caspase-3 expression decreased (<i>P</i> &lt; 0.05). Conclusion: the AI value of low-grade glioma is higher than that of high-grade glioma, indicating that the progression of brain glioma may inhibit cell apoptosis. The increased apoptosis index and the expression changes of GSK-3 β ER stress cell apoptosis pathway in the glioma group indicate that the apoptosis pathway in GSK-3 β ER stress cells was initiated and executed in glioma. In low-grade glioma cells, there may be a mechanism to inhibit IRE 1, ATF 6, PERK, and p-Tyr216-GSK-3 β expression, which further promotes cell apoptosis and inhibited tumor progression. And with the progression of glioma, The expression of IRE 1, ATF 6, PERK, GRP78, and p-Tyr216-GSK-3 β was gradually increased, The expression of P-Ser 9-GSK-3 β, Caspase-3 was gradually decreased, It indicates that GRP78, IRE 1, ATF 6, PERK and p-Tyr216-GSK-3 β may be involved in the progression of glioma; Meanwhile, brain glioma cells may, by inhibiting the expression of P-Ser 9-GSK-3 β and the apoptosis executive protein Caspase-3, Further inhibited the apoptosis of brain glioma cells, promoted the progression of brain glioma. Inhibiting the expression of IRE 1, ATF 6, PERK, GRP78 and p‑Tyr216-GSK-3 β may be of great significance to inhibiting the progression of glioma, which provides a strong basis for guiding the precision treatment of clinical glioma.</p>","PeriodicalId":19119,"journal":{"name":"Neurochemical Journal","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurochemical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1134/s1819712424020156","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Glioma accounts for 80% of malignant central nervous system, with high incidence and extremely difficult to cure. However, for the role of ER stress apoptosis in tumor has caused great attention, the neuronal polarity molecule glycogen synthase kinase-3 β(GSK-3 β) endoplasmic network stress apoptosis pathway in tumor mechanism is a hot research in recent years, but for GSK-3 β ER stress apoptosis pathway in different levels of glioma research is extremely rare. In this experiment, we jointly explored the significance of GSK-3 β ER apoptosis pathway in different grades of glioma, which provided a strong basis for the precise treatment of glioma. 35 inpatients from December 2021 to December 2022 were enrolled into the different grades of glioma group and the normal control group. Tumor tissue was classified according to medical pathology. The other five normal brain tissues were obtained from the normal brain tissue of the fistula created in non-functional areas. One of the brain samples was stored for the apoptosis index (AI) of TUNEL (chromogenic method), and another part was stored in liquid nitrogen for the expression of GRP78, IRE 1, ATF 6, PERK, p-Tyr216-GSK-3 β, p-Ser 9-GSK-3 β, and Caspase-3. The AI values of different grades of glioma and normal control groups showed that the normal control, low-grade glioma and high-grade glioma groups were 8. 131 ± 0.234, 68.523 ± 1.392 and 22. 421 ± 0.236, respectively. The AI value was higher in the glioma group than in the normal controls (P < 0.05), while the AI value in the glioma group was negatively correlated with its malignancy (r = –0.725, P = 0.000). Western blot showed: compared with the normal control group, apoptosis initiation protein GRP78 expression, IRE 1, ATF 6, PERK decreased (P < 0.05); pathway key protein p-Ser 9-GSK-3 β increased, and p-Tyr216-GSK-3 β decreased (P < 0.05); pathway executive protein Caspase-3 increased (P < 0.05). However, the apoptosis initiation protein GRP78, IRE 1, ATF 6, PERK increased (P < 0.05); pathway key protein p-Ser 9-GSK-3 β decreased and p-Tyr216-GSK-3 β was increased (P < 0.05); pathway execution protein Caspase-3 expression decreased (P < 0.05). Conclusion: the AI value of low-grade glioma is higher than that of high-grade glioma, indicating that the progression of brain glioma may inhibit cell apoptosis. The increased apoptosis index and the expression changes of GSK-3 β ER stress cell apoptosis pathway in the glioma group indicate that the apoptosis pathway in GSK-3 β ER stress cells was initiated and executed in glioma. In low-grade glioma cells, there may be a mechanism to inhibit IRE 1, ATF 6, PERK, and p-Tyr216-GSK-3 β expression, which further promotes cell apoptosis and inhibited tumor progression. And with the progression of glioma, The expression of IRE 1, ATF 6, PERK, GRP78, and p-Tyr216-GSK-3 β was gradually increased, The expression of P-Ser 9-GSK-3 β, Caspase-3 was gradually decreased, It indicates that GRP78, IRE 1, ATF 6, PERK and p-Tyr216-GSK-3 β may be involved in the progression of glioma; Meanwhile, brain glioma cells may, by inhibiting the expression of P-Ser 9-GSK-3 β and the apoptosis executive protein Caspase-3, Further inhibited the apoptosis of brain glioma cells, promoted the progression of brain glioma. Inhibiting the expression of IRE 1, ATF 6, PERK, GRP78 and p‑Tyr216-GSK-3 β may be of great significance to inhibiting the progression of glioma, which provides a strong basis for guiding the precision treatment of clinical glioma.

Abstract Image

胶质瘤在 GSK-3 β:内质网应激凋亡通路中的表达差异及其意义研究与分析
摘要 神经胶质瘤占中枢神经系统恶性肿瘤的80%,发病率高且极难治愈。然而,对于ER应激凋亡在肿瘤中的作用却引起了极大的关注,神经元极性分子糖原合酶激酶-3 β(GSK-3 β)内质网应激凋亡通路在肿瘤中的作用机制是近年来的研究热点,但对于GSK-3 β ER应激凋亡通路在胶质瘤不同层面的研究却极为少见。本实验中,我们共同探讨了GSK-3 β ER凋亡通路在不同级别胶质瘤中的意义,为胶质瘤的精准治疗提供了有力依据。该研究将2021年12月至2022年12月的35名住院患者分为不同等级胶质瘤组和正常对照组。肿瘤组织根据医学病理学进行分类。另外五份正常脑组织取自无功能区瘘管的正常脑组织。其中一份脑组织样本被保存用于TUNEL(显色法)的凋亡指数(AI)检测,另一份脑组织样本被保存在液氮中,用于检测GRP78、IRE 1、ATF 6、PERK、p-Tyr216-GSK-3 β、p-Ser 9-GSK-3β和Caspase-3的表达。不同级别胶质瘤和正常对照组的 AI 值显示,正常对照组、低级别胶质瘤组和高级别胶质瘤组的 AI 值分别为 8.131±0.234、68.523±1.392和22.421 ± 0.236。胶质瘤组的 AI 值高于正常对照组(P < 0.05),而胶质瘤组的 AI 值与其恶性程度呈负相关(r = -0.725,P =0.000)。Western blot显示:与正常对照组相比,凋亡起始蛋白GRP78表达量、IRE 1、ATF 6、PERK减少(P <0.05);通路关键蛋白p-Ser 9-GSK-3 β增加,p-Tyr216-GSK-3 β减少(P <0.05);通路执行蛋白Caspase-3增加(P <0.05)。但凋亡启动蛋白GRP78、IRE 1、ATF 6、PERK增加(P <0.05);通路关键蛋白p-Ser 9-GSK-3 β减少,p-Tyr216-GSK-3 β增加(P <0.05);通路执行蛋白Caspase-3表达减少(P <0.05)。结论:低分化胶质瘤的AI值高于高级别胶质瘤,说明脑胶质瘤的进展可能抑制细胞凋亡。胶质瘤组细胞凋亡指数升高,GSK-3 β ER应激细胞凋亡通路表达变化,说明胶质瘤中GSK-3 β ER应激细胞凋亡通路启动并执行。在低级别胶质瘤细胞中,可能存在抑制IRE 1、ATF 6、PERK和p-Tyr216-GSK-3 β表达的机制,从而进一步促进细胞凋亡,抑制肿瘤进展。而随着脑胶质瘤的进展,IRE 1、ATF 6、PERK、GRP78和p-Tyr216-GSK-3 β的表达逐渐升高,P-Ser 9-GSK-3β、Caspase-3的表达逐渐降低,这表明GRP78、IRE 1、ATF 6、PERK和p-Tyr216-GSK-3 β可能参与了脑胶质瘤的进展;同时,脑胶质瘤细胞可能通过抑制 P-Ser 9-GSK-3 β 和凋亡执行蛋白 Caspase-3 的表达,进一步抑制脑胶质瘤细胞的凋亡,促进脑胶质瘤的进展。抑制IRE 1、ATF 6、PERK、GRP78和p-Tyr216-GSK-3 β的表达可能对抑制脑胶质瘤的进展具有重要意义,为指导临床脑胶质瘤的精准治疗提供了有力依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurochemical Journal
Neurochemical Journal 医学-神经科学
自引率
20.00%
发文量
40
审稿时长
>12 weeks
期刊介绍: Neurochemical Journal (Neirokhimiya) provides a source for the communication of the latest findings in all areas of contemporary neurochemistry and other fields of relevance (including molecular biology, biochemistry, physiology, neuroimmunology, pharmacology) in an afford to expand our understanding of the functions of the nervous system. The journal presents papers on functional neurochemistry, nervous system receptors, neurotransmitters, myelin, chromaffin granules and other components of the nervous system, as well as neurophysiological and clinical aspects, behavioral reactions, etc. Relevant topics include structure and function of the nervous system proteins, neuropeptides, nucleic acids, nucleotides, lipids, and other biologically active components. The journal is devoted to the rapid publication of regular papers containing the results of original research, reviews highlighting major developments in neurochemistry, short communications, new experimental studies that use neurochemical methodology, descriptions of new methods of value for neurochemistry, theoretical material suggesting novel principles and approaches to neurochemical problems, presentations of new hypotheses and significant findings, discussions, chronicles of congresses, meetings, and conferences with short presentations of the most sensational and timely reports, information on the activity of the Russian and International Neurochemical Societies, as well as advertisements of reagents and equipment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信